"Gene Products, gag" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen.
| Descriptor ID |
D015683
|
| MeSH Number(s) |
D12.776.775.330 D12.776.964.775.350 D12.776.964.970.600.850.350
|
| Concept/Terms |
Gene Products, gag- Gene Products, gag
- gag Polyprotein
- Polyprotein, gag
- gag Polyproteins
- Polyproteins, gag
- gag Protein
- Protein, gag
- Retroviral Antigen gag Protein
- Viral gag Proteins
- Proteins, Viral gag
- gag Proteins, Viral
- Gene Product, gag
- gag Gene Product
- gag Gene Products
- gag Antigens
- Antigens, gag
- gag Viral Proteins
- Proteins, gag Viral
- Viral Proteins, gag
|
Below are MeSH descriptors whose meaning is more general than "Gene Products, gag".
Below are MeSH descriptors whose meaning is more specific than "Gene Products, gag".
This graph shows the total number of publications written about "Gene Products, gag" by people in this website by year, and whether "Gene Products, gag" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Products, gag" by people in Profiles.
-
Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV. Vaccine. 2016 11 21; 34(48):5886-5894.
-
Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein. PLoS One. 2015; 10(7):e0133509.
-
Improving Mycobacterium bovis bacillus Calmette-Gu?rin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells. PLoS One. 2014; 9(9):e108383.
-
HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity. PLoS One. 2014; 9(2):e90100.
-
Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag. J Virol. 2014 Feb; 88(3):1492-501.
-
Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein. Clin Cancer Res. 2013 Nov 15; 19(22):6112-25.
-
Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins. Biochem J. 2010 Dec 15; 432(3):525-34.
-
Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry. Retrovirology. 2010 Sep 20; 7:75.
-
A recoding method to improve the humoral immune response to an HIV DNA vaccine. PLoS One. 2008 Sep 15; 3(9):e3214.
-
The HIV-1 p6/EIAV p9 docking site in Alix is autoinhibited as revealed by a conformation-sensitive anti-Alix monoclonal antibody. Biochem J. 2008 Sep 01; 414(2):215-20.